Contrast-Induced Nephropathy Archives - Page 5 of 5 - Renal and Urology News

Contrast-Induced Nephropathy

Targeted Renal Therapy May Stop CIN

WASHINGTON, D.C.—Targeted renal therapy (TRT) involving intrarenal administration of fenoldopam is safe and feasible in patients undergoing angiographic procedures, even in patients at elevated risk of suffering from contrast-induced nephropathy (CIN).

N -Acetylcysteine is Renoprotective

A recent meta-analysis supports administration of N-acetylcysteine prophylaxis to prevent contrast-induced nephropathy, especially in high-risk patients. Researchers also noted that the drug is inexpensive and readily available, and has few side effects.

Next post in News